遗传决定的血小板特征通过多种机制和细胞类型影响中风风险
medRxiv : the preprint server for health sciences
|August 13, 2025
概括
血小板特征,包括血小板数量和体积,显著增加中风风险. 新的方法确定了与血小板功能和内皮细胞粘附相关的特定遗传通路,为中风预防提供了新的见解.
科学领域:
- 心血管科学 心血管科学
- 遗传学 遗传学 是一个
- 血液学 血液学 血液学
背景情况:
- 卒中是全球死亡和残疾的主要原因之一.
- 目前的抗血小板和抗凝固疗法存在局限性.
- 遗传性血液和血小板特征在中风风险中的作用尚未完全理解.
研究的目的:
- 为了确定因果关系的血液相关细胞和影响中风风险的机制.
- 确定血小板特征对中风病原发生的特定贡献.
- 探索中风中血小板特征的遗传基础.
主要方法:
- 采用双样本门德尔随机化 (MR) 评估因果关系.
- 贝叶斯模型平均 (MR-BMA) 确定了与中风相关的关键血液特征.
- 噪音增强定向聚类 (NAvMix) 分析了血小板计数的遗传变异.
- 对已识别的遗传位点进行了路径和同地化分析.
主要成果:
- 增加的血小板数和平均血小板体积被确定为中风的重要危险因素.
- 两个不同的血小板数变异集群强烈预测了中风风险的增加.
- 途径分析显示了对内皮细胞粘附和血小板反应性的丰富.
- 通过血小板特征,RIN3,PEX6和PEX29等基因与中风风险有关.
结论:
- 血小板特征是中风风险的关键决定因素,超过其他血细胞特征.
- 影响血小板数量和反应性的遗传变异在中风的发病过程中起着关键作用.
- 新的MR方法与子集群结合,可以阐明相关特征的复杂因果机制.
相关概念视频
Structure and Function of Platelets
1.5K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.5K
Formation of the Platelet Plug
7.1K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
903
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
903
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
645
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
645
Clot Retraction and Fibrinolysis
6.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.8K
Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K


